Rigel Pharmaceuticals Inc...

NASDAQ: RIGL · Real-Time Price · USD
21.51
0.54 (2.58%)
At close: Jun 06, 2025, 3:59 PM
20.51
-4.65%
After-hours: Jun 06, 2025, 05:55 PM EDT

Rigel Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Contract revenues from collaborations Revenue 34.38M -42.76M 39.02M 75.73M 40.36M 8.7M 30.56M
Contract revenues from collaborations Revenue Growth -180.39% -209.58% -48.47% +87.64% +364.10% -71.55% n/a
Discounts and allowances Revenue -65.02M 147.06M -31.8M -18.18M n/a n/a n/a
Discounts and allowances Revenue Growth -144.22% -562.37% +74.98% n/a n/a n/a n/a
Gross product sales Revenue 209.92M 104.29M 108.52M 81.19M n/a n/a n/a
Gross product sales Revenue Growth +101.28% -3.90% +33.67% n/a n/a n/a n/a
License Revenue 14M n/a 76.72M 63.01M n/a n/a n/a
License Revenue Growth n/a n/a +21.76% n/a n/a n/a n/a
Product sales, net Revenue 144.9M n/a n/a n/a n/a n/a n/a
Product sales, net Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 27.71M 29.52M 27.04M 28.05M 28.45M 26.85M 24.86M 26.31M 27.73M 32.17M 25.9M 26.98M 27.4M 24.52M 22.88M 22.38M 22.12M 21.82M 17.43M 18.92M 18.43M 18.31M 18.12M 18.21M 19.95M 21.37M 18.07M 17.07M 13.49M 14.65M 7.95M 7.82M 7.41M 7.15M 4.56M 4.77M 4.42M 4.72M 4.28M 4.1M 4.72M
Selling, General, and Administrative Revenue Growth -6.11% +9.16% -3.58% -1.41% +5.96% +8.02% -5.51% -5.13% -13.81% +24.23% -4.02% -1.53% +11.77% +7.16% +2.23% +1.16% +1.39% +25.17% -7.88% +2.66% +0.64% +1.05% -0.48% -8.71% -6.66% +18.27% +5.85% +26.53% -7.93% +84.40% +1.62% +5.53% +3.59% +56.93% -4.52% +7.94% -6.31% +10.41% +4.32% -13.10% n/a
Research and Development Revenue 8.44M 5.63M 6.18M 5.54M 6.03M 3.19M 6.47M 4.77M 10.09M 15.37M 14.67M 14.77M 15.47M 13.3M 18.3M 16.81M 16.83M 15.14M 14.6M 14.21M 16.15M 14.25M 14.46M 13.23M 10.95M 13.77M 11.1M 10.8M 11.24M 11.56M 10.81M 11.52M 12.38M 11.63M 16.17M 17.47M 18.17M 16.56M 15.5M 15.06M 15.7M
Research and Development Revenue Growth +49.79% -8.90% +11.59% -8.07% +89.14% -50.80% +35.69% -52.70% -34.34% +4.77% -0.68% -4.57% +16.31% -27.30% +8.88% -0.11% +11.15% +3.68% +2.72% -11.98% +13.35% -1.49% +9.35% +20.80% -20.47% +24.06% +2.78% -3.96% -2.76% +6.97% -6.21% -6.88% +6.38% -28.06% -7.43% -3.88% +9.72% +6.85% +2.94% -4.10% n/a